# PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence

> **NCT07335289** · NA · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 400 (estimated)

## Conditions studied

- HIV Pre-exposure Prophylaxis Use

## Interventions

- **OTHER:** Choice of follow up
- **OTHER:** Follow up via standard clinic

## Key facts

- **NCT ID:** NCT07335289
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-02
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07335289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07335289, "PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07335289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*